ExpiredContract NoticeSuppliesTED 90/2026
Medicines for the Treatment of Rare Diseases in the Republic of North Macedonia for the Period May 2026 – December 2028
Contracting Authority
Publication (OJ)
May 8, 2026
Submission Deadline
Jun 8, 2026
Estimated Value
€308
Contract Duration
36.0 months
Procedure Type
Open procedure
Lots
11
Buyer headquarters
Skopje — MK008
Sector
Description
Medicines for the Treatment of Rare Diseases in the Republic of North Macedonia for the Period May 2026 – December 2028
CPV Codes
33680000336621003362210033641300336617003363230033612000336522003365230033673000
Lots (11)
LOT-0001N07XX06, tetrabenazine, 25 mg, tablet, tablet
3366170036 months
Award criteria
Lowest price
LOT-0002M01CC01, penicillamine, 250 mg, tablet/capsule, tablet/capsule
3363230036 months
Award criteria
Lowest price
LOT-0003A16AX07, sapropterin, 100 mg, tablet/powder for oral solution, tablet/sachet
3361200036 months
Award criteria
Lowest price
LOT-0004C02DA01, diazoxide, 50 mg, capsule/hard tablet, capsule/hard tablet
3365220036 months
Award criteria
Lowest price
LOT-0005N03AG04, vigabatrin, 500 mg, film-coated tablet/tablet for oral solution, tablet
3366170036 months
Award criteria
Lowest price
LOT-0006N03AX17, stiripentol, 250 mg, hard capsule/powder for oral suspension, hard capsule/powder for oral suspension
3366170036 months
Award criteria
Lowest price
LOT-0007L01EM03, alpelisib, 50 mg, film-coated tablet, tablet
3365230036 months
Award criteria
Lowest price
LOT-0008A05AX04, maralixibat, 9.5 mg/1 ml, oral solution, bottle
3361200036 months
Award criteria
Lowest price
LOT-0009R03DX09, mepolizumab, 100 mg/1 ml, solution for injection, pre-filled pen/syringe
3367300036 months
Award criteria
Lowest price
LOT-0010L01XX74, belzutifan, 40 mg, film-coated tablet, tablet
3365230036 months
Award criteria
Lowest price
LOT-0011C10AX13, evolocumab, 140 mg/1 ml, solution for injection, pre-filled pen/syringe
3365220036 months
Award criteria
Lowest price